Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
We evaluate common budgeting methods to identify which is most effective for different financial situations. Learn practical steps to implement it.
24,193 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
March PMI data show slowing U.S. growth with rising costs. Bitcoin reacts nervously, facing renewed macro risk as tra...
Three top clean energy ETFs have surged more than 50% over the past year, offering divergent paths to the green trans...
Navitas NVTS and ON Semiconductor are capturing attention as AI data-center demand climbs. Analysts see a potential r...
NVIDIA still leads the AI chip race, but investors are spreading bets downstream to adjacent AI opportunities as the ...
When headlines hit geopolitics, crypto markets react fast. This piece explains why bitcoin and ethereum slip in respo...
A notable pullback in semiconductor stocks has sharpened the buying case for a diversified chip ETF. As earnings beat...
When a mining stock pops, traders look beyond a single catalyst. This article breaks down why coeur mining stock popp...
GameStop's latest SEC filing confirms it still holds 4,710 BTC, ending weeks of speculation over on-chain moves. The ...
The Nasdaq Composite extended gains as bulls maintain control amid stronger tech deal activity, improving chip profit...
A robot rollout tied to Melania Trump ignites a national debate over funding and the future of public schools. The te...
A former antitrust prosecutor who helped litigate the JetBlue-Spirit merger shares lessons for future airline regulat...